• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday

    2/16/24 10:09:19 AM ET
    $AMAT
    $AORT
    $BIO
    $BLZE
    Semiconductors
    Technology
    Medical/Dental Instruments
    Health Care
    Get the next $AMAT alert in real time by email

    U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Friday.

    Shares of Applied Materials, Inc. (NASDAQ:AMAT) rose sharply in today’s session after the company reported better-than-expected first-quarter financial results and issued second-quarter guidance.

    Applied Materials reported quarterly earnings of $2.13 per share which beat the analyst consensus estimate of $1.91 by 11.52%. The company reported quarterly sales of $6.71 billion, beating the analyst consensus estimate of $6.48 billion by 3.55%, and representing a 0.47% decrease over sales of $6.74 billion from the same period last year.

    Applied Materials shares jumped 8.3% to $203.27 on Friday.

    Here are some other big stocks recording gains in today’s session.

    • PRA Group, Inc. (NASDAQ:PRAA) shares jumped 23.4% to $30.25 following upbeat results.
    • The Trade Desk, Inc. (NASDAQ:TTD) shares gained 21% to $91.66 after the company reported mixed fourth-quarter financial results.
    • Nano-X Imaging Ltd. (NASDAQ:NNOX) rose 19% to $11.31. Nvidia recently reported a 59,632 share stake in the company.
    • Backblaze, Inc. (NASDAQ:BLZE) jumped 17.2% to $9.55 after the company reported better-than-expected fourth-quarter financial results and issued full year 2024 revenue guidance above estimates.
    • Toast, Inc. (NYSE:TOST) climbed 16.6% to $22.39 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter adjusted subscription services and financial technology solutions guidance. Also the company authorized a $250 million share repurchase program.
    • Coinbase Global, Inc. (NASDAQ:COIN) shares gained 15.8% to $191.79 as the company reported better-than-expected financial results for its fourth quarter on Thursday.
    • Nayax Ltd. (NASDAQ:NYAX) climbed 15.6% to $30.99. Nayax is expected to report fourth-quarter earnings on Feb. 28, 2024.
    • Kinsale Capital Group, Inc. (NYSE:KNSL) rose 13.1% to $495.00 following upbeat quarterly results.
    • Gyre Therapeutics, Inc. (NASDAQ:GYRE) gained 11.9% to $17.88.
    • Texas Roadhouse, Inc. (NASDAQ:TXRH) rose 10% to $147.30 after the company reported better-than-expected fourth-quarter GAAP EPS results. Also, Wedbush and Stephens & Co raised their respective price targets on the stock.
    • HireRight Holdings Corporation (NYSE:HRT) climbed 9.8% to $14.12 as the company agreed to be acquired by General Atlantic and Stone Point Capital.
    • Shockwave Medical, Inc. (NASDAQ:SWAV) gained 9.6% to $258.98 after the company reported better-than-expected fourth-quarter financial results.
    • Sarepta Therapeutics, Inc. (NASDAQ:SRPT) surged 7.9% to $134.73 after the FDA accepted and filed the company's efficacy supplement to the Biologics License Application for ELEVIDYS.
    • Bio-Rad Laboratories, Inc. (NYSE:BIO) jumped 7.1% to $352.10 following upbeat earnings.
    • Vulcan Materials Company (NYSE:VMC) gained 5.6% to $256.08 following strong results.
    • Artivion, Inc. (NASDAQ:AORT) gained 4.1% to $18.78 following strong quarterly results.
    • DT Midstream, Inc. (NYSE:DTM) rose 4% to $54.51 following upbeat earnings.

     

    Now Read This: Top 4 Health Care Stocks You May Want To Dump In February

    Get the next $AMAT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMAT
    $AORT
    $BIO
    $BLZE

    CompanyDatePrice TargetRatingAnalyst
    The Trade Desk Inc.
    $TTD
    3/16/2026$25.00Sell → Neutral
    Arete
    The Trade Desk Inc.
    $TTD
    3/6/2026$23.00Neutral → Underperform
    Wedbush
    Applied Materials Inc.
    $AMAT
    3/5/2026Hold
    Erste Group
    Vulcan Materials Company (Holding Company)
    $VMC
    3/4/2026$320.00Overweight → Neutral
    Analyst
    The Trade Desk Inc.
    $TTD
    2/26/2026$17.00Neutral → Sell
    New Street
    The Trade Desk Inc.
    $TTD
    2/26/2026$25.00Buy → Hold
    Loop Capital
    Kinsale Capital Group Inc.
    $KNSL
    2/25/2026$348.00Market Perform → Underperform
    BMO Capital Markets
    Backblaze Inc.
    $BLZE
    2/24/2026$4.50Buy → Hold
    Craig Hallum
    More analyst ratings

    $AMAT
    $AORT
    $BIO
    $BLZE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Green Jeffrey Terry was granted 398,089 shares and bought $148,101,266 worth of Class A Common Stock (6,000,000 units at $24.68), increasing direct ownership by 154% to 655,917 units (SEC Form 4)

    4 - Trade Desk, Inc. (0001671933) (Issuer)

    3/4/26 8:27:33 PM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    Executive V.P., CFO Jewell Jeffrey A bought $25,221 worth of shares (185 units at $136.33), increasing direct ownership by 0.21% to 89,583 units (SEC Form 4)

    4 - DT Midstream, Inc. (0001842022) (Issuer)

    2/25/26 4:23:14 PM ET
    $DTM
    Natural Gas Distribution
    Utilities

    Director Share Gregory M bought $1,048,460 worth of shares (2,675 units at $391.95) (SEC Form 4)

    4 - Kinsale Capital Group, Inc. (0001669162) (Issuer)

    12/17/25 4:16:27 PM ET
    $KNSL
    Property-Casualty Insurers
    Finance

    $AMAT
    $AORT
    $BIO
    $BLZE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Sever Michal claimed ownership of 5,341 units of Ordinary Shares (SEC Form 3)

    3 - Nayax Ltd. (0001901279) (Issuer)

    3/16/26 1:55:44 PM ET
    $NYAX
    Computer Software: Prepackaged Software
    Technology

    New insider Aharon Yaron claimed ownership of 8,794 units of Ordinary Shares (SEC Form 3)

    3 - Nayax Ltd. (0001901279) (Issuer)

    3/16/26 1:54:24 PM ET
    $NYAX
    Computer Software: Prepackaged Software
    Technology

    SEC Form 3 filed by new insider Raz-Avayo Vered

    3 - Nayax Ltd. (0001901279) (Issuer)

    3/16/26 1:45:20 PM ET
    $NYAX
    Computer Software: Prepackaged Software
    Technology

    $AMAT
    $AORT
    $BIO
    $BLZE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    The Trade Desk upgraded by Arete with a new price target

    Arete upgraded The Trade Desk from Sell to Neutral and set a new price target of $25.00

    3/16/26 8:34:06 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    The Trade Desk downgraded by Wedbush with a new price target

    Wedbush downgraded The Trade Desk from Neutral to Underperform and set a new price target of $23.00

    3/6/26 8:26:23 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    Erste Group initiated coverage on Applied Materials

    Erste Group initiated coverage of Applied Materials with a rating of Hold

    3/5/26 9:06:39 AM ET
    $AMAT
    Semiconductors
    Technology

    $AMAT
    $AORT
    $BIO
    $BLZE
    SEC Filings

    View All

    SEC Form 144 filed by Coinbase Global Inc.

    144 - Coinbase Global, Inc. (0001679788) (Subject)

    3/16/26 12:39:08 PM ET
    $COIN
    Finance: Consumer Services
    Finance

    SEC Form F-3 filed by NANO-X IMAGING LTD

    F-3 - Nano-X Imaging Ltd. (0001795251) (Filer)

    3/13/26 5:20:31 PM ET
    $NNOX
    Medical Electronics
    Health Care

    SEC Form 8-K filed by Applied Materials Inc.

    8-K - APPLIED MATERIALS INC /DE (0000006951) (Filer)

    3/13/26 4:54:42 PM ET
    $AMAT
    Semiconductors
    Technology

    $AMAT
    $AORT
    $BIO
    $BLZE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Gyre Therapeutics Announces China's NMPA Grants Priority Review to the NDA for Hydronidone (F351) for CHB-Induced Liver Fibrosis Treatment

    SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (Gyre or Gyre Therapeutics) (NASDAQ:GYRE), a San Diego-based innovative commercial stage biopharmaceutical company with operations in the United States and China, today announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted priority review status to the New Drug Application (NDA) for Hydronidone (F351) as a treatment for chronic hepatitis B (CHB)-induced liver fibrosis, which is liver damage resulting from the infection of the hepatitis B virus (HBV). This decision by CDE was made following the pre-NDA communication meeting previously announced on Januar

    3/17/26 7:00:00 AM ET
    $GYRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sarepta Announces that Screening and Enrollment are Underway in ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne

    - Approximately 25 non-ambulatory participants will receive sirolimus as part of the regimen in Cohort 8 of the ENDEAVOR study - The enhanced immunosuppressive regimen is designed to mitigate the risk of acute liver injury (ALI) and acute liver failure (ALF) associated with AAV gene therapy in non-ambulatory patients Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced screening and enrollment are underway in Cohort 8 of ENDEAVOR (Study 9001-103). The purpose of Cohort 8 is to assess prophylactic sirolimus treatment as part of an enhanced safety protocol during treatment with ELEVIDYS (delandistrogene moxeparvovec-rokl) in

    3/16/26 8:33:00 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.596 Million Tokens, and Total Crypto and Total Cash Holdings of $11.5 Billion

    Bitmine has 3,040,515 staked ETH, representing $6.6 billion at $2,185 per ETH; MAVAN staking solution on track to launch Q1 2026Bitmine now owns 3.81% of the ETH token supply, over 76% of the way to the 'Alchemy of 5%' in just 8 monthsBitmine increased its investment into Eightco (ticker: $ORBS) by $80 million to support ORBS $50 million purchase of OpenAI equity ORBS is now the only publicly listed equity in the world to give investor direct exposure to OpenAIBitmine acquired 5,000 ETH from the Ethereum Foundation (EF) to enable EF to fund its core operationsBitmine Crypto + Total Cash Holdings + "Moonshots" total $11.5 billion, including 4.596 million ETH tokens, total cash of $1.2 billion

    3/16/26 8:30:00 AM ET
    $BMNR
    $COIN
    $MSTR
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    $AMAT
    $AORT
    $BIO
    $BLZE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for AMONDYS 45 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug AMONDYS 45 (SUPPL-8) with active ingredient CASIMERSEN has changed to 'Approval' on 07/11/2024. Application Category: NDA, Application Number: 213026, Application Classification: Labeling

    7/12/24 4:40:36 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 20, 2024 - FDA Expands Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy

    For Immediate Release: June 20, 2024 Today, the U.S. Food and Drug Administration expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene therapy for the treatment of Duchenne muscular dystrophy (DMD) for ambulatory and non-ambulatory individuals 4 years of age and older with DMD with a confirmed mutation in the DMD gene.  Elevidys was previously approved under accelerated approval for amb

    6/20/24 5:24:42 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VYONDYS 53 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug VYONDYS 53 (SUPPL-11) with active ingredient GOLODIRSEN has changed to 'Approval' on 06/04/2024. Application Category: NDA, Application Number: 211970, Application Classification: Labeling

    6/5/24 4:41:31 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMAT
    $AORT
    $BIO
    $BLZE
    Leadership Updates

    Live Leadership Updates

    View All

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    Texas Roadhouse, Inc. Appoints Lisa Ingram to Board of Directors

    LOUISVILLE, Ky., March 05, 2026 (GLOBE NEWSWIRE) -- Texas Roadhouse, Inc. (NASDAQ:TXRH) announced today that Lisa Ingram has been appointed to the Company's Board of Directors. Ms. Ingram is the Chief Executive Officer and Chair of the Board of Directors for White Castle System, Inc., which is based in Columbus, Ohio. White Castle currently has 340 restaurants in 14 states. In addition, the company owns and operates 6 manufacturing plants that supply products to its restaurants and its consumer product goods, which are sold in grocery stores in all 50 states. Known as the "Slider Queen," Ingram has led White Castle since 2015 and is the fourth-generation family member to lead the iconic

    3/5/26 4:05:00 PM ET
    $MHO
    $TXRH
    Homebuilding
    Consumer Discretionary
    Restaurants

    Backblaze Appoints Rhett Dillingham Senior Vice President of Product

    Backblaze adds strategic AI and cybersecurity leader to drive innovation and operational excellence to continue scaling its platform for the AI era Backblaze, Inc. (NASDAQ:BLZE), the high-performance cloud storage platform for the AI era, today announced the appointment of Rhett Dillingham as Senior Vice President of Product, strengthening the company's executive leadership team as its cloud storage platform and AI use cases continue to scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224045978/en/Rhett Dillingham, Senior Vice President of Product at Backblaze Dillingham brings more than two decades of product manageme

    2/24/26 4:01:00 PM ET
    $BLZE
    Computer Software: Prepackaged Software
    Technology

    $AMAT
    $AORT
    $BIO
    $BLZE
    Financials

    Live finance-specific insights

    View All

    Applied Materials Raises Quarterly Cash Dividend by 15 Percent

    SANTA CLARA, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that its Board of Directors has approved a 15-percent increase in the quarterly cash dividend, from $0.46 to $0.53 per share, payable on June 11, 2026 to shareholders of record as of May 21, 2026. This marks nine consecutive years of dividend increases. "With the increase announced today, Applied Materials has more than doubled its dividend per share from four years ago," said Brice Hill, Senior Vice President and CFO. "This demonstrates our ability to generate strong cash flow and attractive shareholder distributions while investing to enable profitable growth." The cash dividend is a key com

    3/13/26 7:30:00 AM ET
    $AMAT
    Semiconductors
    Technology

    VULCAN MATERIALS TO OUTLINE NEW GROWTH AND PROFITABILITY TARGETS AT 2026 INVESTOR DAY

    BIRMINGHAM, Ala., March 12, 2026 /PRNewswire/ -- Vulcan Materials Company (NYSE:VMC), the nation's largest producer of construction aggregates, will set new cash gross profit per ton and earnings targets and outline its strategy for winning the future in aggregates at its 2026 Investor Day event today in New York City. Details about the event, including instructions for the webcast, are provided below.Ronnie Pruitt, Vulcan's Chief Executive Officer, stated, "Vulcan is entering its seventieth year as a public company, and we have been winning in aggregates from the beginning. Our proven aggregates-led strategy, financial strength and flexibility, and advantaged footprint will continue to driv

    3/12/26 7:00:00 AM ET
    $VMC
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    Full-year 2025 revenue increased 10% year-over-year to $116.6 million, within revised guidance range Full year 2026 revenue guidance of $100.5 to $111.0 million Entered into agreement to acquire Cullgen to gain targeted protein degradation platform and pipeline; transaction anticipated to close in the second quarter of 2026 Alignment with China's Center for Drug Evaluation (CDE) on conditional approval filing and priority review eligibility for Hydronidone, subject to formal approval; New Drug Application (NDA) submission for conditional approval expected in the first half of 2026 Completed patient enrollment in the 52-week Phase 3 pirfenidone pneumoconiosis (PD) trial(272 patients acros

    3/12/26 6:00:00 AM ET
    $GYRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMAT
    $AORT
    $BIO
    $BLZE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Coinbase Global Inc.

    SC 13G/A - Coinbase Global, Inc. (0001679788) (Subject)

    11/14/24 5:44:24 PM ET
    $COIN
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13G/A filed by Coinbase Global Inc.

    SC 13G/A - Coinbase Global, Inc. (0001679788) (Subject)

    11/14/24 5:40:50 PM ET
    $COIN
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13G/A filed by The Trade Desk Inc.

    SC 13G/A - Trade Desk, Inc. (0001671933) (Subject)

    11/14/24 4:42:28 PM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology